Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - trientine dihydrochloride, quantity: 250 mg - capsule - excipient ingredients: magnesium stearate; titanium dioxide; macrogol 3350; gelatin; iron oxide yellow; purified water; colloidal anhydrous silica - trientine dihydrochloride capsules are indicated for the treatment of patients with wilson's disease who are intolerant of penicillamine.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - trientine dihydrochloride - capsule - excipient ingredients: magnesium stearate; titanium dioxide; macrogol 3350; purified water; gelatin; iron oxide yellow; colloidal anhydrous silica - trientine dihydrochloride capsules are indicated for the treatment of patients with wilson's disease who are intolerant of penicillamine.

Australia - English - Department of Health (Therapeutic Goods Administration)

waymade australia pty limited - trientine dihydrochloride, quantity: 250 mg - capsule - excipient ingredients: gelatin; stearic acid; titanium dioxide; purified water; sunset yellow fcf; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - trientine waymade is indicated in the treatment of patients with wilson?s disease who are intolerant of penicillamine.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - trientine dihydrochloride, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; magnesium stearate; purified water; gelatin; iron oxide yellow; macrogol 3350; colloidal anhydrous silica - trientine dihydrochloride capsules are indicated for the treatment of patients with wilson's disease who are intolerant of penicillamine.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - trientine dihydrochloride 250mg - capsule - 250 mg - active: trientine dihydrochloride 250mg excipient: gelatin stearic acid sunset yellow fcf tekprint black sw-9008 titanium dioxide water - trientine waymade is indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride 250 mg - trientine hydrochloride is indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. trientine hydrochloride and penicillamine cannot be considered interchangeable. trientine hydrochloride should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride is not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment. trientine hydrochloride is not indicated f

United States - English - NLM (National Library of Medicine)

oceanside pharmaceutials - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride 250 mg - trientine hydrochloride capsules are indicated in the treatment of patients with wilson’s disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsules is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient’s dose have not been well defined. trientine hydrochloride capsules and penicillamine cannot be considered interchangeable. trientine hydrochloride capsules should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsules are not recommended in cystinuria or rheumatoid arthritis. the absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride capsules were reported not to be effective in improving any clinical or biochemical parameter after 12 weeks

Ireland - English - HPRA (Health Products Regulatory Authority)

tillomed pharma gmbh - trientine dihydrochloride - capsule, hard - trientine

Israel - English - Ministry of Health

raz pharmaceutics ltd, israel - trientine dihydrochloride - capsules - trientine dihydrochloride 250 mg - trientine - for the treatment of wilson’s disease in patient's intolerant of d-penicillaminetherapy, in adults, adolescents and children aged 5 years or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - trientine dihydrochloride - capsule - excipient ingredients: iron oxide yellow; titanium dioxide; gelatin; magnesium stearate; purified water; macrogol 3350; colloidal anhydrous silica - trientine dihydrochloride capsules are indicated for the treatment of patients with wilson's disease who are intolerant of penicillamine.